MiR-128-1 is continuously inhibited in hyperlipidaemic Apoe/mice, resulting in a significant reduction in hepatic steatosis, VLDL-associated TAGs and circulating VLDL-C/LDL-C. Here, APOE is linked to Hepatic steatosis.